ArticleFrontiers in oncology2022

An exploratory study on the checkout rate of circulating tumor cells and the prediction of efficacy of neoadjuvant therapy and prognosis in patients with HER-2-positive early breast cancer.

Jinmei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.